drugset / Trial / NCT02734732

Antibiotic Prophylaxis for Transrectal Prostate Biopsy-Ciprofloxacin vs. Trimethoprim/Sulfamethoxazole

NCT02734732

Phase 2 Unknown 2800 enrolled Umeå University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This study will examine if a single dose of Ciprofloxacin and Trimethoprim/Sulfamethoxazole are equivalent for prophylaxis immediately prior to prostate biopsy, when a patient has a suspected prostate cancer.

Timeline

Start
2015-04
Primary completion
2020-04
Completion
2020-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ciprofloxacin Small molecule 750 mg
Comparator Sulfamethoxazole Small molecule 800 mg
Comparator Trimethoprim Small molecule 160 mg

Indications